Skip to main content


Health

During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
375 of 1583



Newsletter Sign Up

Daily Readings

Reading 1, Ephesians 2:12-22
do not forget, I say, that you were at that time separate from ... Read More

Psalm, Psalms 85:9-10, 11-12, 13-14
His saving help is near for those who fear him, his glory will ... Read More

Gospel, Luke 12:35-38
'See that you have your belts done up and your lamps lit. Be ... Read More

Saint of the Day

October 21 Saint of the Day

St. Hilarion
October 21: Abbot and disciple of St. Anthony the Great, companion of St. ... Read More